Wir ExamFragen bieten Ihnen die umfassendsten Salesforce ALS-Con-201 Dumps mit sehr hoher Hit-Rate. Und alle Probleme, die vielleicht in aktuellen Prüfungen sind in Dumps vorhanden. Und wir aktualisieren unsere Dumps nach der Veränderung der Prüfungsinhalte. Es kann den sinnlosen Zeitaufwand vermeiden und Ihnen helfen, leichter und hocheffektiver die Salesforce ALS-Con-201 Prüfung zu bestehen. Obwohl Sie dieSalesforce ALS-Con-201 Prüfung nicht bestehen, geben wir Ihnen voll Geld zurück. Deshalb können Sie keinen Verlust haben. Die Chance ist für die Leute, die gut bereit sind. Wir hoffen, dass Sie keine gut Chance verlieren.
| Certification Vendor: | Salesforce |
|---|---|
| Exam Name: | Salesforce Certified Agentforce Life Sciences Consultant Exam |
| Exam Number: | ALS-Con-201 |
| Passing Score: | 62% |
| Available Languages: | English |
| Related Certifications: | Salesforce Certified Data 360 Consultant Salesforce Certified Platform Administrator Salesforce Certified Agentforce Specialist |
| Exam Format: | Multiple-choice, Multiple-select, Scenario-based questions |
| Exam Duration: | 105 minutes |
| Real Exam Qty: | 60 scored questions + up to 5 unscored questions |
| Exam Price: | USD 200 (plus applicable taxes) |
| Recommended Training: | Agentforce Life Sciences Consultant Trailhead Path Life Sciences Cloud Customer Engagement Training |
| Exam Registration: | Schedule Salesforce Certification Exam Salesforce Certification Exam Registration |
| Sample Questions: | Salesforce ALS-Con-201 Sample Questions |
| Exam Way: | Online proctored or onsite testing center |
| Pre Condition: | Salesforce recommends experience as a Salesforce Consultant, Architect, Developer, or Business Analyst, plus familiarity with life sciences industry processes. Salesforce Certified Platform Administrator is a required prerequisite. |
| Official Syllabus URL: | https://help.salesforce.com/s/articleView?id=005305357&type=1 |
Eine breite Vielzahl von Salesforce ExamFragen ALS-Con-201 Prüfung Fragen und AntwortenLogische ursprünglichen Exponate für ExamFragen ALS-Con-201 Salesforce Certified Agentforce Life Sciences Consultant Prüfungsfragen100% genaue Antworten von Industrie-Experten gelöstFalls erforderlich aktualisiert Salesforce ExamFragen ALS-Con-201 Prüfungsfragen ExamFragen ALS-Con-201 Fragen und Antworten sind die gleichen wie sie die Real Salesforce Zertifizierungsprüfungen erscheinen. Viele der ExamFragen ALS-Con-201 Salesforce Certified Agentforce Life Sciences Consultant Prüfungsvorbereitung Antworten sind in Vielfache-Wahl-Fragen (MCQs) FormatQualität geprüften Salesforce Certified Agentforce Life Sciences Consultant Produkte viele Male vor der VeröffentlichungKostenlose Demo der Prüfung ExamFragen ALS-Con-201 an ExamFragen.
| Thema | Einzelheiten |
|---|---|
| Thema 1 |
|
| Thema 2 |
|
| Thema 3 |
|
| Thema 4 |
|
66. Frage
Choose 1 option.
Cumulus Pharma wants a medical inquiry process configured where only a designated persona can assign and respond to medical inquiries.
Which configuration supports this compliance requirement?
Antwort: A
Begründung:
Option B is correct because Salesforce Life Sciences Medical Inquiries uses workflow actions and persona/profile-based configuration to control who can perform specific inquiry actions, such as assigning and responding. Salesforce Help states that, before setting up Medical Inquiry, admins must make sure the required user profiles, licenses, and permission sets are in place. It also describes that medical science liaisons can assign and respond to inquiries, which confirms that these actions are intended to be controlled by role or persona.
Salesforce's Life Sciences workflow documentation also identifies workflow actions and workflow stages as part of the Medical Inquiry management setup. The Medical Inquiries workflow setup includes action buttons, workflow stages, stage operations, and conditions, allowing admins to expose or restrict actions based on configured roles and workflow state.
Option A is not the best answer because the requirement is not simply to grant a broad app permission; it is to ensure that only a designated persona can perform the assign and respond actions in the controlled Medical Inquiry process. Option C is incorrect because a custom formula field only affects display logic and does not enforce the standard workflow-action permission model. Formula-based visibility also creates compliance risk because it can hide buttons without truly governing the underlying operation. Therefore, the consultant should create workflow actions and associate those actions with the appropriate profiles in the Life Sciences Admin Console.
=========
67. Frage
Choose 1 option.
A field sales rep bulk deletes several planned visits from the calendar for an upcoming week and then notices that two visits still appear on the calendar.
Why are these visits still visible?
Antwort: B
Begründung:
The correct answer is C because Life Sciences Calendar can display visits where the user is not the owner but is included as an attendee or visitor. Salesforce Life Sciences Visit Management supports adding internal users as visitors to a visit so that colleagues participating in the same HCP interaction can be recorded and the visit can be shared with them. Salesforce also describes Life Sciences Calendar as a place to visualize and prioritize key activities, including visits and other events, and Trailhead explains that reps can view colleagues' visits in shared calendars to coordinate engagement.
In this scenario, the rep bulk deleted several planned visits from their calendar. The two remaining visits are likely not visits owned and managed by the rep. Instead, they are visits owned by another user where the rep is included as an attendee. Because the calendar is configured to show attendee visits, those records continue to appear even after the rep deletes their own planned visits.
Option A is incorrect because the issue is not tied to the selected account list. Option B is plausible for some filtered-calendar behavior, but the key clue is that only some visits remain visible after bulk deletion. The standard Life Sciences explanation is that attendee visits can remain visible because they belong to a colleague and are displayed for collaboration. Therefore, the visits remain because the rep is added as an attendee.
=========
68. Frage
Choose 1 option.
An Agentforce Life Sciences Consultant has finished configuring the Q4 Launch Plan and set the status to "In Progress." However, field sales reps report that they cannot see the plan or their targets on their dashboards. The Start Date is today. The system requires a specific batch process to transition the plan from "In Progress" to "Active" based on the start date.
Which job must the consultant run in the Admin Console?
Antwort: A
Begründung:
The correct answer is B because the issue is the Activity Plan status transition. Salesforce describes Activity Plans as the mechanism to establish strategic plans and define activity goals for sales representatives over a specific period. The Life Sciences Activity Plans developer guidance also explains that activity plans define goals for employees, including targeted accounts, plan-cycle duration, activity types, and progress tracking.
In this scenario, the plan exists and has a Start Date of today, but it is still in In Progress status. Reps cannot see the plan or their targets because the plan has not moved into the operational Active state. The specific job designed for this is Update Activity Plan Status, which evaluates the plan's dates and moves eligible plans from In Progress to Active. Running that job makes the plan available for execution and dashboard reporting.
Option A is incorrect because Activity Plan Trigger Handler suggests trigger-based automation, not the named batch process that transitions plan status according to dates. Option C, Validate Activity Plans, is also incorrect because validation checks whether the plan setup is correct; it does not perform the status transition required by the question. The consultant should run Update Activity Plan Status in the Admin Console.
=========
69. Frage
Choose 1 option.
An Agentforce Life Sciences Consultant needs to configure sample management rules. They must specify which types of Healthcare Organizations (HCOs) are eligible to receive samples and enforce that users must enter a batch number for every sample dropped.
Which subsection of Visit Settings should the consultant use for these configurations?
Antwort: C
Begründung:
The correct answer is C because the requirement is about sampling eligibility and validation behavior during visits. Salesforce Life Sciences sample management features support compliant handling and distribution of samples, and visit-related sample behavior is configured through visit settings and sample management setup. Salesforce Help describes sample management as enabling pharmaceutical companies to efficiently handle and distribute drug samples to providers, while the broader Customer Engagement setup includes Life Sciences mobile and visit configuration areas where these rules are applied.
The scenario includes two validation-style requirements. First, the consultant must specify which types of HCOs are eligible to receive samples. Second, the system must require users to enter a batch number for every sample drop. Both requirements are about enforcing rules during the sampling process, not about presenting product details or general sample item display.
Option A, Product Detailing Settings, is incorrect because product detailing is used to configure how products are discussed or presented during an engagement. It does not control HCO sample eligibility or mandatory batch entry. Option B, Samples and Items Settings, sounds related to sample availability, but the requirement is specifically about compliance validation. Option C, Sample and Validation Settings, is the correct subsection because it governs sample-related validation behavior, including eligibility and required information such as batch number entry. Therefore, the consultant should use Sample and Validation Settings.
=========
70. Frage
Choose 1 option.
At Cumulus Pharma, field sales reps report that the Next Best Action component is not visible on the account profile, even though the recommendation data is confirmed to be loaded and synced to mobile.
What is the cause of this issue?
Antwort: B
Begründung:
Option B is correct because Life Sciences Cloud for Customer Engagement uses Life Sciences-specific Next Best components for the mobile and account-profile experience. Salesforce's Life Sciences Next Best documentation explains that Next Best Action suggests timely actions such as visits and emails, and the Life Sciences Customer Engagement data model includes Life Sciences-specific recommendation objects such as Territory Account Recommended Action, Territory Account Product Message Score, and Territory Account Score. These are not the same as the generic Einstein Next Best Action component and strategy experience.
The question states that the recommendation data is already loaded and synced to mobile. That removes the most likely data-load or synchronization issue. If the data exists but the component is not visible on the account profile, the issue is most likely the wrong component placement. The page must use the Life Sciences Next Best Action component that is designed to render Life Sciences recommendations in the Life Sciences mobile app.
Option A is not the best answer because inactive strategy logic would generally prevent recommendations from being generated or returned, but the scenario confirms the recommendation data is present. Option C is also less likely because a permission problem would typically prevent access to the recommendation records or data, not specifically indicate that the component itself was configured incorrectly. Therefore, the consultant should replace the generic Einstein Next Best Action component with the Life Sciences Next Best Action component.
=========
71. Frage
......
ALS-Con-201 Fragenkatalog: https://www.examfragen.de/ALS-Con-201-pruefung-fragen.html